INS and obesity disorder: We examined how HetKO‐GAA impacts metabolic health (i.e., obesity, insulin sensitivity, glucose tolerance, fatty liver) and liver metabolism (i.e., liver glycogen content, liver glucose output, substrate metabolism, and energy expenditure) in a mouse model of HFD‐induced obesity and prediabetes.